TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 7841276

Group type: EXPERIMENTAL
Intervention: Active Compression-Decompression (ACD) using a hand-held suction device (CardioPump, Ambu Int.) with compression (30-50 kp) and decompression (10-15 kp) at a frequency of 80/min.
Number of subjects: 56

Group type: COMPARATOR
Intervention: Standard chest compression according to AHA recommendations.
Number of subjects: 56
Study: 3277481

Group type: EXPERIMENTAL
Intervention: Oral atropine 0.04 mg/kg
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Oral atropine 0.02 mg/kg
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study: 31076307

Group type: EXPERIMENTAL
Intervention: Combined short‐axis‐and‐long‐axis approach (n = 40)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Short‐axis out‐of‐plane approach (SA‐OOP) (n = 40)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Long‐axis in‐plane approach (LA‐IP) (n = 40)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Combined short‐axis‐and‐long‐axis approach vs SA‐OOP
Number of subjects: 120

Group type: COMPARATOR
Intervention: Combined short‐axis‐and‐long‐axis approach vs LA‐IP
Number of subjects: 120
Study: 28521880

Group type: EXPERIMENTAL
Intervention: 0.2-0.3mg HC/kg body weight/day
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: 0.4-0.6mg HC/kg body weight/day
Number of subjects: 46

Group type: COMPARATOR
Intervention: Both doses
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Higher dose
Number of subjects: 46
Study: 26041653

Group type: EXPERIMENTAL
Intervention: Brief behavioural intervention to promote regular self-weighing, including daily weighing encouragement and support materials such as a weight record card
Number of subjects: 560

Group type: COMPARATOR
Intervention: Weight maintenance leaflet, a diagram representing healthy diet composition, and a list of websites for weight control
Number of subjects: 560
Study: 23216882

Group type: EXPERIMENTAL
Intervention: SRP plus chlorhexidine digluconate and dihydrochloride
Number of subjects: 10

Group type: COMPARATOR
Intervention: SRP plus chlorhexidine gluconate
Number of subjects: 10
Study: 21885349

Group type: EXPERIMENTAL
Intervention: Seizures of mesial temporal lobe origin
Number of subjects: 14

Group type: COMPARATOR
Intervention: Interictal periods
Number of subjects: 14
Study: 19358503

Group type: EXPERIMENTAL
Intervention: Opposing needling
Number of subjects: 60

Group type: COMPARATOR
Intervention: Routine acupuncture
Number of subjects: 60
Study: 16428568

Group type: EXPERIMENTAL
Intervention: Subgluteal approach (n = 28)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Popliteal approach (n = 28)
Number of subjects: 56
Study: 15571424

Group type: EXPERIMENTAL
Intervention: IL-2 plus ribavirin
Number of subjects: 60

Group type: COMPARATOR
Intervention: Interferon-alpha-2b plus ribavirin
Number of subjects: 60
Study: 11312429

Group type: EXPERIMENTAL
Intervention: Imiquimod 5% cream applied twice daily for 6 weeks
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Imiquimod 5% cream applied once daily for 6 weeks
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Imiquimod 5% cream applied twice daily 3 times/week for 6 weeks
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Imiquimod 5% cream applied once daily 3 times/week for 6 weeks
Number of subjects: 99
Study: 9209663

Group type: EXPERIMENTAL
Intervention: High GST activity (median: 298 units, range: 50-691)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High GST activity (> 250 units)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High GST activity
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stage III-IV ovarian cancer patients with high GST activity
Number of subjects: 0
Study: 7956718

Group type: EXPERIMENTAL
Intervention: Theophylline (5 mg/kg) in oral solution
Number of subjects: 6
Study: 30804169

Group type: EXPERIMENTAL
Intervention: Faculty feedback
Number of subjects: 126

Group type: COMPARATOR
Intervention: Peer feedback
Number of subjects: 126
Study: 29246455

Group type: EXPERIMENTAL
Intervention: Single-point cane
Number of subjects: 50

Group type: COMPARATOR
Intervention: Self-stretching exercises
Number of subjects: 50
Study: 26683593

Group type: EXPERIMENTAL
Intervention: rt‐PA + Gs
Number of subjects: 2

Group type: COMPARATOR
Intervention: rt‐PA + placebo (Pc)
Number of subjects: 2
Study: 25173483

Group type: EXPERIMENTAL
Intervention: M-001 (500 mcg, non-adjuvanted or adjuvanted)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 120
Study: 22850914

Group type: EXPERIMENTAL
Intervention: Intensive treatment (IT) with weekly visits for medication adjustments and educational plan for six weeks
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Intensive treatment (IT)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Both groups (IT and CT)
Number of subjects: 53
Study: 20348452

Group type: EXPERIMENTAL
Intervention: Calcium dobesilate only (Group A)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Oxerutin only (Group B)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Calcium dobesilate and oxerutin (Group C)
Number of subjects: 150
Study: 18408560

Group type: EXPERIMENTAL
Intervention: Albuterol (short-acting beta2-agonist)
Number of subjects: 607

Group type: EXPERIMENTAL
Intervention: CRHR2 genetic variants
Number of subjects: 607
Study: 15759530

Group type: EXPERIMENTAL
Intervention: Bobath treatment
Number of subjects: 44
Study: 12426503

Group type: EXPERIMENTAL
Intervention: Clinical examination of secondary caries in crowned teeth
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Radiographic evaluation of secondary caries in crowned teeth
Number of subjects: 100

Group type: COMPARATOR
Intervention: Clinical examination of nonrestored teeth
Number of subjects: 100
Study: 10494484

Group type: EXPERIMENTAL
Intervention: CVR with 15 micrograms ethinyl estradiol
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: CVR with 20 micrograms ethinyl estradiol
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Both CVR
Number of subjects: 61
Study: 7794542

Group type: EXPERIMENTAL
Intervention: Structured questionnaires
Number of subjects: 520

Group type: EXPERIMENTAL
Intervention: In-depth interviews
Number of subjects: 520

Group type: COMPARATOR
Intervention: GPA questionnaire
Number of subjects: 520
Study: 1791612

Group type: EXPERIMENTAL
Intervention: nisoldipine 5 mg twice daily
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: nifedipine 10 mg twice daily
Number of subjects: 28

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 28
Study: 6794462

Group type: EXPERIMENTAL
Intervention: salbutamol
Number of subjects: 35

Group type: COMPARATOR
Intervention: placebo (sterile water)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: disodium cromoglycate
Number of subjects: 35
Study: 31452920

Group type: COMPARATOR
Intervention: Standard behavioural treatment
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: ENHANCED (technology-supported treatment with digital scale and Fitbit Zip)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: ENHANCED
Number of subjects: 36

Group type: COMPARATOR
Intervention: Standard behavioural treatment and ENHANCED
Number of subjects: 36
Study: 31154955

Group type: EXPERIMENTAL
Intervention: Access to health information (electronic and print media)
Number of subjects: 4104

Group type: EXPERIMENTAL
Intervention: Wealth improvements in key sectors (education, employment, social protection, housing, and infrastructure)
Number of subjects: 4104

Group type: EXPERIMENTAL
Intervention: Utilization of mosquito nets
Number of subjects: 4104
Study: 27104325

Group type: EXPERIMENTAL
Intervention: Scapula stabilizing t-shirt
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (no t-shirt)
Number of subjects: 32
Study: 24814607

Group type: EXPERIMENTAL
Intervention: Topiramate (TOP)
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Contingent monetary voucher incentives (CM)
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Topiramate (TOP) with Contingent monetary voucher incentives (CM)
Number of subjects: 171

Group type: COMPARATOR
Intervention: Control (Placebo)
Number of subjects: 171
Study: 22490950

Group type: EXPERIMENTAL
Intervention: 0.5% Loteprednol Etabonate ophthalmic suspension
Number of subjects: 34

Group type: COMPARATOR
Intervention: 1% Cyclosporine A eye drops
Number of subjects: 34
Study: 19795444

Group type: EXPERIMENTAL
Intervention: Polymerase chain reaction (PCR) on 1 antral biopsy
Number of subjects: 1948

Group type: COMPARATOR
Intervention: Histopathology (hematoxylin‐eosin and Giemsa staining) on 5 biopsies (antrum and corpus)
Number of subjects: 1948

Group type: EXPERIMENTAL
Intervention: Polymerase chain reaction (PCR) on 1 biopsy
Number of subjects: 1948

Group type: COMPARATOR
Intervention: Histopathology on 5 biopsies
Number of subjects: 1948

Group type: EXPERIMENTAL
Intervention: Polymerase chain reaction (PCR)
Number of subjects: 1948
Study: 17540851

Group type: EXPERIMENTAL
Intervention: 16-slice CT angiography
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: 64-slice CT angiography
Number of subjects: 243
Study: 16158308

Group type: EXPERIMENTAL
Intervention: TGDc‐01 tonometry
Number of subjects: 68

Group type: COMPARATOR
Intervention: Goldmann applanation tonometry
Number of subjects: 68
Study: 12021221

Group type: EXPERIMENTAL
Intervention: tirofiban/heparin
Number of subjects: 0

Group type: COMPARATOR
Intervention: heparin alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: tirofiban
Number of subjects: 0
Study: 10208508

Group type: EXPERIMENTAL
Intervention: Model topical agent
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo control
Number of subjects: 14
Study: 7762709

Group type: EXPERIMENTAL
Intervention: Community-wide education in Pawtucket
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison community
Number of subjects: 0
Study: 1972611

Group type: EXPERIMENTAL
Intervention: Acebutolol (0.1 mg/kg i.v. bolus over 30 s)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Esmolol (loading dose 500 micrograms/kg over 1 min followed by 100 micrograms/kg per min continuous infusion)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (no specific control group mentioned)
Number of subjects: 20
Study: 418585

Group type: EXPERIMENTAL
Intervention: Oral thyrotropin releasing hormone (TRH) 40 mg
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 31765428

Group type: COMPARATOR
Intervention: Four-component combination pill (polypill)
Number of subjects: 0
Study: 29512470

Group type: EXPERIMENTAL
Intervention: Olaparib
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Niraparib
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rucaparib
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Talazoparib
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Veliparib
Number of subjects: 0
Study: 27640727

Group type: EXPERIMENTAL
Intervention: Hypodermoclysis administered by caregivers after a 45-minute training session
Number of subjects: 21
Study: 24794289

Group type: EXPERIMENTAL
Intervention: Serious games (SG) as an adjuvant to conventional treatment
Number of subjects: 352

Group type: COMPARATOR
Intervention: Conventional treatment for CP
Number of subjects: 352
Study: 22421927

Group type: EXPERIMENTAL
Intervention: Lorcaserin 10 mg BID
Number of subjects: 604

Group type: EXPERIMENTAL
Intervention: Lorcaserin 10 mg QD
Number of subjects: 604

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 604
Study: 20380655

Group type: EXPERIMENTAL
Intervention: Liraglutide 0.6 mg/day
Number of subjects: 264

Group type: EXPERIMENTAL
Intervention: Liraglutide 0.9 mg/day
Number of subjects: 264

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 264
Study: 18025845

Group type: EXPERIMENTAL
Intervention: Periprostatic bupivacaine (0.5% 20 ml) injection (group I)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Total tramadol consumption in group I
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Patient-controlled analgesia demands in group I
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (saline NaCl 0.9% 20 ml injection, group II)
Number of subjects: 40
Study: 16192551

Group type: EXPERIMENTAL
Intervention: Valsalva maneuver (blew into sphygmomanometer tubing and raised the mercury column up to 30 mm Hg for 20 s)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Ball pressing (pressed a rubber ball)
Number of subjects: 75
Study: 12831918

Group type: EXPERIMENTAL
Intervention: Toupet fundoplication (TF)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Nissen‐Rossetti fundoplication (NF)
Number of subjects: 33
Study: 10671817

Group type: EXPERIMENTAL
Intervention: GDM group (n=33)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Normal pregnant women (n=62)
Number of subjects: 41
Study: 8848917

Group type: EXPERIMENTAL
Intervention: Low flow rate anesthesia with heat moisture exchanger
Number of subjects: 40

Group type: COMPARATOR
Intervention: High fresh gas flow rates with heat moisture exchanger
Number of subjects: 40
Study: 1535653

Group type: EXPERIMENTAL
Intervention: Korean HBV vaccine
Number of subjects: 922

Group type: COMPARATOR
Intervention: U.S. HBV vaccine
Number of subjects: 922

Group type: EXPERIMENTAL
Intervention: Both vaccines
Number of subjects: 922
Study: 6532586

Group type: EXPERIMENTAL
Intervention: Administration of a specific vasopressin antagonist acting at the vascular site
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cigarette smoking
Number of subjects: 0
Study: 30460746

Group type: EXPERIMENTAL
Intervention: First spectacles for myopia (SE ≤ -6.00 D in either eye)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Parental myopia
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Younger age at baseline
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Higher myopia at baseline
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: More time spent on reading and close work
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Less time spent outdoors
Number of subjects: 240
Study: 27923475

Group type: EXPERIMENTAL
Intervention: Pediatric orthopedists (Group A)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Non-pediatric orthopedists (Group B)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 88
Study: 25336324

Group type: EXPERIMENTAL
Intervention: LM low viscosity pectin beverage
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: LM high viscosity pectin beverage
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: HM low viscosity pectin beverage
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: HM high viscosity pectin beverage
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: LMA pectin beverage
Number of subjects: 25
Study: 24709034

Group type: EXPERIMENTAL
Intervention: 10,000U of rimabotulinumtoxinB (n=8)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 15,000U of rimabotulinumtoxinB (n=8)
Number of subjects: 24
Study: 22439244

Group type: COMPARATOR
Intervention: Plates (group A)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Absorbable screws (group B)
Number of subjects: 97
Study: 19568205

Group type: EXPERIMENTAL
Intervention: Aerobic training
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Resistance training
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Combined aerobic and resistance exercise training
Number of subjects: 103

Group type: COMPARATOR
Intervention: Waiting-list control
Number of subjects: 103
Study: 17276802

Group type: EXPERIMENTAL
Intervention: Specialized emergency nurses (SENs)
Number of subjects: 512

Group type: COMPARATOR
Intervention: House officers (HOs)
Number of subjects: 512
Study: 15247733

Group type: EXPERIMENTAL
Intervention: 12/15Fr Applied Access Forte XE (Applied Medical)
Number of subjects: 54

Group type: COMPARATOR
Intervention: 12/14Fr Cook Flexor (Cook Urological)
Number of subjects: 54
Study: 12202470

Group type: EXPERIMENTAL
Intervention: Calcium supplementation
Number of subjects: 1806
Study: 9578335

Group type: EXPERIMENTAL
Intervention: Psyllium (7.4 g)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 7523130

Group type: EXPERIMENTAL
Intervention: Neoadjuvant hormonal treatment with GnRH analogue (triptorelin) for 3 months
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (no hormonal treatment)
Number of subjects: 56
Study: 2694858

Group type: EXPERIMENTAL
Intervention: Alfentanil combination anaesthesia
Number of subjects: 50

Group type: COMPARATOR
Intervention: Ethrane inhalation anaesthesia
Number of subjects: 50
Study: 902677

Group type: COMPARATOR
Intervention: Indomethacin alone (preparation C)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Indomethacin-antacid combination (preparation A)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Indomethacin-antacid combination (preparation B)
Number of subjects: 12
Study: 30272192

Group type: EXPERIMENTAL
Intervention: Pulmonary nodule detection
Number of subjects: 269

Group type: COMPARATOR
Intervention: Normal CT group
Number of subjects: 269
Study: 28146251

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Analysis System of Psychotherapy (CBASP)
Number of subjects: 268

Group type: COMPARATOR
Intervention: Supportive Psychotherapy (SP)
Number of subjects: 268
Study: 25805645

Group type: EXPERIMENTAL
Intervention: l-DOPA
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: methylphenidate
Number of subjects: 61
Study: 25086659

Group type: EXPERIMENTAL
Intervention: RIS+OLZ (augmentation with olanzapine)
Number of subjects: 60

Group type: COMPARATOR
Intervention: RIS-OLZ (switching to olanzapine)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: OLZ-RIS (augmentation with risperidone)
Number of subjects: 60

Group type: COMPARATOR
Intervention: OLZ+RIS (switching to risperidone)
Number of subjects: 60
Study: 22458865

Group type: EXPERIMENTAL
Intervention: 16 week high-load strength training program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Maintain habitual activity level (Control)
Number of subjects: 0
Study: 19640677

Group type: EXPERIMENTAL
Intervention: Individual cognitive-behavioral family-based therapy (CBFT)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Group cognitive-behavioral family-based therapy (CBFT)
Number of subjects: 38
Study: 17714334

Group type: EXPERIMENTAL
Intervention: Botulinum toxin (BTX) treatment
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control group (healthy individuals)
Number of subjects: 9
Study: 14615876

Group type: EXPERIMENTAL
Intervention: Psilocybin (PY) - 45 microg/kg (very low dose)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Psilocybin (PY) - 115 microg/kg (low dose)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Psilocybin (PY) - 215 microg/kg (medium dose)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Psilocybin (PY) - 315 microg/kg (high dose)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 8
Study: 11437771

Group type: EXPERIMENTAL
Intervention: Continuous positive airway pressure (CPAP) at 7.5 cmH2O
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard technique using Mapleson A breathing system
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Continuous positive airway pressure (CPAP)
Number of subjects: 20
Study: 9728858

Group type: EXPERIMENTAL
Intervention: Nitrous oxide (inspired nitrous oxide >50%)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Non-nitrous oxide
Number of subjects: 20
Study: 8166470

Group type: EXPERIMENTAL
Intervention: Prophylactic cranial irradiation (PCI)
Number of subjects: 0
Study: 3056751

Group type: EXPERIMENTAL
Intervention: Adjuvant hormono-chemotherapy (Tamoxifen for 6 months, and 6-monthly cycles of vincristine, adriamycin, and cyclophosphamide)
Number of subjects: 157

Group type: COMPARATOR
Intervention: Control group (no adjuvant therapy)
Number of subjects: 157
Study: 519956

Group type: EXPERIMENTAL
Intervention: Propranolol (single oral dose)
Number of subjects: 5
Study: 31602811

Group type: EXPERIMENTAL
Intervention: Aflibercept and navigated laser (group A)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Aflibercept and conventional laser (group B)
Number of subjects: 37
Study: 30278428

Group type: EXPERIMENTAL
Intervention: Synbiotics (Simbioflora, Farmoquimica, São Paulo, Brazil)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo (maltodextrin)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Synbiotics
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study: 27567268

Group type: EXPERIMENTAL
Intervention: Early Abstainers
Number of subjects: 954
Study: 25932848

Group type: EXPERIMENTAL
Intervention: Individually tailored, motivationally matched exercise intervention for 12 weeks
Number of subjects: 352

Group type: COMPARATOR
Intervention: Health and wellness comparison intervention
Number of subjects: 352
Study: 28136072

Group type: EXPERIMENTAL
Intervention: Pazopanib (800 mg once daily for up to 24 months)
Number of subjects: 940

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 940

Group type: EXPERIMENTAL
Intervention: Pazopanib
Number of subjects: 940
Study: 21932561

Group type: EXPERIMENTAL
Intervention: Stepwise increase in the extent of combined salmoterol/fluticason therapy
Number of subjects: 543

Group type: EXPERIMENTAL
Intervention: Long-term stable-dose salmoterol/fluticason therapy
Number of subjects: 543

Group type: COMPARATOR
Intervention: Salmoterol/fluticason therapy with gradual decrease of the dose and/or transition to an alternative variant
Number of subjects: 543
Study: 19825213

Group type: EXPERIMENTAL
Intervention: Fermented milk containing Lactobacillus acidophilus 145 and Bifidobacterium longum BB536 (125 g three times a day for 4 weeks)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Regular yoghurt (control group)
Number of subjects: 34
Study: 17383282

Group type: EXPERIMENTAL
Intervention: Nesiritide
Number of subjects: 900

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 900
Study: 15193791

Group type: EXPERIMENTAL
Intervention: Dentine bonding agent (DBA) - Prime & Bond NT applied after acid-etching
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group - No DBA applied
Number of subjects: 34
Study: 10678381

Group type: EXPERIMENTAL
Intervention: Medtronic Freestyle valve
Number of subjects: 76

Group type: COMPARATOR
Intervention: Homograft valve
Number of subjects: 76
Study: 9098819

Group type: EXPERIMENTAL
Intervention: Topical 0.01% dexamethasone sodium phosphate drops
Number of subjects: 12

Group type: COMPARATOR
Intervention: 0.01% timolol maleate drops
Number of subjects: 12
Study: 8487598

Group type: EXPERIMENTAL
Intervention: Nimodipine (90 mg/d)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Nicardipine (60 mg/d)
Number of subjects: 50